Aetna Unveils 2027 Medicare Plans With $0 Copay Benefits
Aetna's 2027 Medicare plans expand zero-copay access to drugs, preventive screenings, and in-home health visits for eligible members.
Aetna has announced its 2027 Medicare plan lineup, highlighting a series of cost-reduction features aimed at making routine and preventive care more accessible for enrolled seniors. The insurer is positioning the new offerings around member value, with an emphasis on eliminating out-of-pocket costs at the point of care for a range of common services.
Among the most prominent features, plan members would face no copays on Tier 1 prescription drugs and covered vaccines when using in-network pharmacies. The zero-copay structure also extends to key preventive screenings — including annual physicals, colonoscopies, and mammograms — when obtained through in-network providers, a benefit designed to reduce financial barriers to early detection and routine wellness care.
Read more Virtual Home Closings Explained: What Buyers and Sellers Should Know →
Aetna is additionally incorporating $0 copay coverage for annual Healthy Home Visits conducted by licensed clinicians from Signify Health, a home-based care platform. Such visits are increasingly used by Medicare insurers to identify health risks in members who may face mobility or transportation challenges that limit traditional clinic access.
The plan design reflects a broader competitive dynamic in the Medicare Advantage market, where insurers have faced mounting pressure to balance rich benefit offerings against tightening reimbursement rates from federal regulators. Aetna's decision to anchor its 2027 pitch around cost certainty for members — particularly on preventive services — signals a strategic bet that affordability messaging will resonate with beneficiaries navigating annual open enrollment decisions.
Continue reading at All Financial Services & Investing.
